BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 24934700)

  • 1. Overdose with modified-release paracetamol (Panadol Osteo®) presenting to a metropolitan emergency medicine network: a case series.
    Graudins A
    Emerg Med Australas; 2014 Aug; 26(4):398-402. PubMed ID: 24934700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early presentation following overdose of modified-release paracetamol (Panadol Osteo) with biphasic and prolonged paracetamol absorption.
    Graudins A; Pham HN; Salonikas C; Naidoo D; Chan B
    N Z Med J; 2009 Aug; 122(1300):64-71. PubMed ID: 19701261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdose with modified-release paracetamol results in delayed and prolonged absorption of paracetamol.
    Graudins A; Chiew A; Chan B
    Intern Med J; 2010 Jan; 40(1):72-6. PubMed ID: 20561368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose.
    Duffull SB; Isbister GK
    Clin Toxicol (Phila); 2013; 51(8):772-6. PubMed ID: 23964853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram line crossing after acetaminophen combination product overdose.
    Kirschner RI; Rozier CM; Smith LM; Jacobitz KL
    Clin Toxicol (Phila); 2016; 54(1):40-6. PubMed ID: 26567585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine.
    Cairney DG; Beckwith HK; Al-Hourani K; Eddleston M; Bateman DN; Dear JW
    Clin Toxicol (Phila); 2016 Jun; 54(5):405-10. PubMed ID: 27108714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracetamol poisoning in adolescents in an Australian setting: not quite adults.
    Graudins A
    Emerg Med Australas; 2015 Apr; 27(2):139-44. PubMed ID: 25752743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol toxicity: what would be the implications of a change in Australian treatment guidelines?
    Wong A; Graudins A; Kerr F; Greene SL
    Emerg Med Australas; 2014 Apr; 26(2):183-7. PubMed ID: 24708009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose.
    Wong A; Sivilotti MLA; Graudins A
    Clin Toxicol (Phila); 2017 Jun; 55(5):346-351. PubMed ID: 28421844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective observational study of a novel 2-phase infusion protocol for the administration of acetylcysteine in paracetamol poisoning.
    Isbister GK; Downes MA; Mcnamara K; Berling I; Whyte IM; Page CB
    Clin Toxicol (Phila); 2016; 54(2):120-6. PubMed ID: 26691690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model.
    Tan C; Graudins A
    Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2).
    Chiew AL; Isbister GK; Kirby KA; Page CB; Chan BSH; Buckley NA
    Clin Toxicol (Phila); 2017 Dec; 55(10):1055-1065. PubMed ID: 28644687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose.
    Woo OF; Mueller PD; Olson KR; Anderson IB; Kim SY
    Ann Emerg Med; 2000 Apr; 35(4):363-8. PubMed ID: 10736123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand.
    Chiew AL; Reith D; Pomerleau A; Wong A; Isoardi KZ; Soderstrom J; Buckley NA
    Med J Aust; 2020 Mar; 212(4):175-183. PubMed ID: 31786822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of new UK paracetamol overdose guidelines on patients presenting to the emergency department.
    Nfila G; Lee S; Binchy J
    Ir Med J; 2014 Feb; 107(2):47-8. PubMed ID: 24654483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified release paracetamol overdose: a prospective observational study (ATOM-3).
    Chiew AL; Isbister GK; Page CB; Kirby KA; Chan BSH; Buckley NA
    Clin Toxicol (Phila); 2018 Sep; 56(9):810-819. PubMed ID: 29451045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness, acceptability and application of paracetamol overdose management guidelines in a New Zealand emergency department.
    Fountain JS; Hawwari H; Kerr K; Holt A; Reith D
    N Z Med J; 2014 Sep; 127(1402):20-9. PubMed ID: 25228418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose.
    Schmidt LE
    Clin Toxicol (Phila); 2013 Jul; 51(6):467-72. PubMed ID: 23697458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and outcomes of paracetamol poisoning management in Hamad Medical Corporation, Qatar: A retrospective cohort study.
    Abushanab D; Gasim M; Devi D; Elbdairy M; Elqasass H; Ahmed N; Vincent M; Abdul Rouf PV; Mohammed HR; Hail MA; Thomas B; Elkassem W; Hanssens Y; Elgassim M; Elmoheen A; Azad A; Mohammed S; Salem W
    Medicine (Baltimore); 2023 Sep; 102(38):e34872. PubMed ID: 37746996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.